USDC CCTP Coming to Morph, Expands Cross-Chain Settlements
Morph will host USDC and Circle's Cross-Chain Transfer Protocol, enabling standardized, cross-chain settlement for pa...
Understanding the ideal retirement planning timeline is crucial for securing your future. Learn how to effectively plan your retirement.
13,883 articlesMorph will host USDC and Circle's Cross-Chain Transfer Protocol, enabling standardized, cross-chain settlement for pa...
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Urban air mobility could redefine city travel, and Archer Aviation sits at the center of that promise. This guide bre...
Evernorth has filed Form S-4 as it advances a merger with Armada Acquisition Corp. II to take a Nasdaq-listed XRP tre...
Disney stock has pulled back in 2026, raising the big question for investors: should disney stock? be part of a longe...
Smart investors look beyond the loud headlines. This guide explains how overlooked stocks soar 2026 by spotting catal...
As Daré gears up to discuss Q1 2026 results, investors will scrutinize cash runway, pipeline milestones, and strategi...
Solana is testing the Alpenglow upgrade with validator trials and a potential Q3 mainnet. Analysts weigh timing, risk...
Crypto traders reacted to reports that Sam Bankman-Fried is seeking a presidential pardon, sending the FTT token shar...
Fox faced a sharp weekly decline as it moved to acquire Roku. This article breaks down the catalysts, financing, and ...
Comcast plans a two‑unit split, separating media operations from connectivity services. Investors responded with a 24...
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...